CEPH Message Board - Msg: 2680381

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jonathan Rothschild who wrote (495)	11/9/1997 8:58:00 PM
From: virgil vancleave	Read Replies (1) of 998

this is my opinion here for what its worth. after spending some research time on fundamental and some tech analysis, it appears that cephalon is positioned better than most give it credit for. could be the reason for all the bullish options and volume trading lately. if stock was in 20's i would be worried about possible downside, but it is at its long long term baseline of 10.5 to 12.5 and the company has enough cash for a few more years at a minimum. PLUS it seems they have been getting some drugs approved overseas and have plans to do so here in the us. seems this fact has been overlooked. company has ties to some big names like chiron and others. the fda decision if favorable could have some serious upside potential, with an unfavorable decision possibly not even affecting the stock as it was already factored in a while back when price fell from 30 to where it is now, back in its base. another fact i find quite interesting is that NO insiders have sold and about 8+ million shares are held by insiders. hope i am right, as it would be nice to have another big winner.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next